Okagbare’s Ban: Nigeria Disqualified From 2022 World Athletics Championships 4x100m Relay
By Our Correspondent
Nigeria will not take part in the 2022 World Athletics Championship 4x100m relay following extended ban handed to Blessing Okagbare in the wake of her anti-doping violations, www.bestchoicesports.com.ng can report.
The Athletics Integrity Unit, AIU of the Word Athletics, WA announced that banned Nigerian sprinter Blessing Okagbare has been found to have committed additional anti-doping rule violations – specifically evading sample collection, and tampering or attempted tampering with the doping control process.
While Okagbare has had her current 10-year ban from athletics extended by one year (now 11 years in total), another significant consequence of this decision against her is that Nigeria has lost its potential qualification place for the women’s 4x100m relay at next month’s World Athletics Championships Oregon22.
This is because six days after Okagbare evaded sample collection (13 June 2021), she competed in the 4x100m relay event at the Nigeria Olympic Trials, with her relay squad qualifying for this year’s World Championships.
All individual and relay results involving Okagbare, from 13 June 2021, are now disqualified under the rules.
Head of the Athletics Integrity Unit (AIU), Brett Clothier, is encouraging athletes and entourage to report suspected doping, noting the unscrupulous behaviour of dopers could have damning repercussions for their team-mates and country.
His comments come in the wake of already-banned Nigerian sprinter Blessing Okagbare being found to have committed additional anti-doping rule violations.
“Over the years, we have repeatedly seen how one person’s actions adversely affect team-mates who have trained hard and worked honestly for their results,” noted Clothier.
“In a relay team, if one member violates the anti-doping rules, everyone bears the brunt of results being expunged. They all pay the price. In this instance, Nigeria has lost an important qualification spot. Those are the rules and we will not compromise on integrity.”
On 14 February, 2022, the Disciplinary Tribunal banned Okagbare for 10 years; consecutive five-year bans for the presence and use of multiple prohibited substances, and for her refusal to co-operate with the AIU’s investigation into her case. The prohibited substances were human Growth Hormone (hGH) and recombinant erythropoietin (EPO). This decision stemmed from charges which the AIU brought against Ms Okagbare on 07 October, 2021. Details can be read here.
On 10 June, 2022, the AIU further charged Ms Okagbare with Evading Sample Collection, and Tampering or Attempted Tampering with the Doping Control process. These charges related to the circumstances of the athlete’s Whereabouts Failure on 13 June, 2021, and were pursued based on information in a criminal charge, brought against US-based “naturopathic” therapist Eric Lira, on 12 January, 2022, by the United States Department of Justice under the Rodchenkov Act. Mr Lira is alleged to have supplied performance-enhancing drugs to athletes before the Tokyo 2020 Olympic Games (delayed until summer 2021 because of the Covid-19 pandemic).
The complaint against Mr Lira provides specific information of his interaction with a person named ‘Athlete 1’, including a written exchange on or around 13 June, 2021, demonstrating that ‘Athlete 1’ knowingly and deliberately avoided testing by a Doping Control Officer in Jacksonsville, Florida. There was also other pertinent information about ‘Athlete 1’ in the criminal complaint which led the AIU Disciplinary Tribunal’s sole arbitrator to be “comfortably satisfied” that ‘Athlete 1’ is Blessing Okagbare, including text conversations imaged from Ms Okagbare’s mobile phone by the Federal Bureau of Investigation (FBI).
Ms Okagbare failed to respond to the charges by the extended deadline (21 June, 2022) and is therefore deemed to have admitted the anti-doping rule violations (under Rule 2.3 and Rule 2.5 of the World Athletics Anti-Doping Rules) and to have accepted the consequences.